[1]
R. Clark, D. Bozkaya, M. Levenberg, S. Faulkner, T. W. Smith, and R. A. Gerber, “Topical Treatment Utilization for Patients with Atopic Dermatitis in the United States and Budget Impact Analysis of Crisaborole Ointment, 2%”, J of Skin, vol. 1, no. 3.1, p. s43, Oct. 2017.